Loading…

Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro

Background Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from Salvia miltiorrhiza that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear....

Full description

Saved in:
Bibliographic Details
Published in:Aesthetic plastic surgery 2023-08, Vol.47 (4), p.1587-1597
Main Authors: Chong, Chio-Hou, Sun, Jia-Ming, Liu, Yu-Xin, Tsai, Yi-Tung, Zheng, Dan-Ning, Zhang, Yi-Fan, Yu, Li
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193
cites cdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193
container_end_page 1597
container_issue 4
container_start_page 1587
container_title Aesthetic plastic surgery
container_volume 47
creator Chong, Chio-Hou
Sun, Jia-Ming
Liu, Yu-Xin
Tsai, Yi-Tung
Zheng, Dan-Ning
Zhang, Yi-Fan
Yu, Li
description Background Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from Salvia miltiorrhiza that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B in vitro and in vivo . Methods In vitro , hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR. In vivo , tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&E, Masson, picrosirius red staining, and immunofluorescence. Results In vitro, Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs. In vivo , 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model. Conclusions Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model in vivo . No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
doi_str_mv 10.1007/s00266-023-03279-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2779346317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2843961453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</originalsourceid><addsrcrecordid>eNp9kD9PwzAQxS0EoqXwBRiQJRaWgP_FTsZSUYpUwVBAbJbrOJAqsYudVOq3x5ACEgO33Envd-_sB8ApRpcYIXEVECKcJ4jQBFEi8gTvgSFmlCQpYXgfDBHlLCGYvwzAUQgrhDARgh2CAeUZRhklQ3C_UPWmUtbVlYZjXRXwGo7b1thOtSbA2XZtfOvd-i3KC608nDrfqLZyFt5Z-FxtHFS26OfIHYODUtXBnOz6CDxNbx4ns2T-cHs3Gc8TTUXaJipDTOdcFyIVLM-XmhJOM1ymisfScTCkxEZpbli6LBWnhhGkMWFRzXBOR-Ci9117996Z0MqmCtrUtbLGdUHGf-aUcYpFRM__oCvXeRtfJ0nGaM4xS2mkSE9p70LwppRrXzXKbyVG8jNt2actY9ryK22J49LZzrpbNqb4WfmONwK0B0KU7Kvxv7f_sf0AHp-IIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2843961453</pqid></control><display><type>article</type><title>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</title><source>Springer Nature</source><creator>Chong, Chio-Hou ; Sun, Jia-Ming ; Liu, Yu-Xin ; Tsai, Yi-Tung ; Zheng, Dan-Ning ; Zhang, Yi-Fan ; Yu, Li</creator><creatorcontrib>Chong, Chio-Hou ; Sun, Jia-Ming ; Liu, Yu-Xin ; Tsai, Yi-Tung ; Zheng, Dan-Ning ; Zhang, Yi-Fan ; Yu, Li</creatorcontrib><description>Background Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from Salvia miltiorrhiza that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B in vitro and in vivo . Methods In vitro , hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR. In vivo , tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&amp;E, Masson, picrosirius red staining, and immunofluorescence. Results In vitro, Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs. In vivo , 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model. Conclusions Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model in vivo . No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</description><identifier>ISSN: 0364-216X</identifier><identifier>EISSN: 1432-5241</identifier><identifier>DOI: 10.1007/s00266-023-03279-1</identifier><identifier>PMID: 36810832</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Evidence-based medicine ; Medicine ; Medicine &amp; Public Health ; Original Article ; Otorhinolaryngology ; Plastic Surgery</subject><ispartof>Aesthetic plastic surgery, 2023-08, Vol.47 (4), p.1587-1597</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</citedby><cites>FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36810832$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chong, Chio-Hou</creatorcontrib><creatorcontrib>Sun, Jia-Ming</creatorcontrib><creatorcontrib>Liu, Yu-Xin</creatorcontrib><creatorcontrib>Tsai, Yi-Tung</creatorcontrib><creatorcontrib>Zheng, Dan-Ning</creatorcontrib><creatorcontrib>Zhang, Yi-Fan</creatorcontrib><creatorcontrib>Yu, Li</creatorcontrib><title>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</title><title>Aesthetic plastic surgery</title><addtitle>Aesth Plast Surg</addtitle><addtitle>Aesthetic Plast Surg</addtitle><description>Background Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from Salvia miltiorrhiza that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B in vitro and in vivo . Methods In vitro , hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR. In vivo , tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&amp;E, Masson, picrosirius red staining, and immunofluorescence. Results In vitro, Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs. In vivo , 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model. Conclusions Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model in vivo . No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</description><subject>Evidence-based medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Original Article</subject><subject>Otorhinolaryngology</subject><subject>Plastic Surgery</subject><issn>0364-216X</issn><issn>1432-5241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kD9PwzAQxS0EoqXwBRiQJRaWgP_FTsZSUYpUwVBAbJbrOJAqsYudVOq3x5ACEgO33Envd-_sB8ApRpcYIXEVECKcJ4jQBFEi8gTvgSFmlCQpYXgfDBHlLCGYvwzAUQgrhDARgh2CAeUZRhklQ3C_UPWmUtbVlYZjXRXwGo7b1thOtSbA2XZtfOvd-i3KC608nDrfqLZyFt5Z-FxtHFS26OfIHYODUtXBnOz6CDxNbx4ns2T-cHs3Gc8TTUXaJipDTOdcFyIVLM-XmhJOM1ymisfScTCkxEZpbli6LBWnhhGkMWFRzXBOR-Ci9117996Z0MqmCtrUtbLGdUHGf-aUcYpFRM__oCvXeRtfJ0nGaM4xS2mkSE9p70LwppRrXzXKbyVG8jNt2actY9ryK22J49LZzrpbNqb4WfmONwK0B0KU7Kvxv7f_sf0AHp-IIw</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Chong, Chio-Hou</creator><creator>Sun, Jia-Ming</creator><creator>Liu, Yu-Xin</creator><creator>Tsai, Yi-Tung</creator><creator>Zheng, Dan-Ning</creator><creator>Zhang, Yi-Fan</creator><creator>Yu, Li</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20230801</creationdate><title>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</title><author>Chong, Chio-Hou ; Sun, Jia-Ming ; Liu, Yu-Xin ; Tsai, Yi-Tung ; Zheng, Dan-Ning ; Zhang, Yi-Fan ; Yu, Li</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Evidence-based medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Original Article</topic><topic>Otorhinolaryngology</topic><topic>Plastic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chong, Chio-Hou</creatorcontrib><creatorcontrib>Sun, Jia-Ming</creatorcontrib><creatorcontrib>Liu, Yu-Xin</creatorcontrib><creatorcontrib>Tsai, Yi-Tung</creatorcontrib><creatorcontrib>Zheng, Dan-Ning</creatorcontrib><creatorcontrib>Zhang, Yi-Fan</creatorcontrib><creatorcontrib>Yu, Li</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Aesthetic plastic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chong, Chio-Hou</au><au>Sun, Jia-Ming</au><au>Liu, Yu-Xin</au><au>Tsai, Yi-Tung</au><au>Zheng, Dan-Ning</au><au>Zhang, Yi-Fan</au><au>Yu, Li</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro</atitle><jtitle>Aesthetic plastic surgery</jtitle><stitle>Aesth Plast Surg</stitle><addtitle>Aesthetic Plast Surg</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>47</volume><issue>4</issue><spage>1587</spage><epage>1597</epage><pages>1587-1597</pages><issn>0364-216X</issn><eissn>1432-5241</eissn><abstract>Background Hypertrophic scars (HTSs) are a fibroproliferative disorder that occur following skin injuries. Salvianolic acid B (Sal-B) is an extractant from Salvia miltiorrhiza that has been reported to ameliorate fibrosis in multiple organs. However, the antifibrotic effect on HTSs remains unclear. This study aimed to determine the antifibrotic effect of Sal-B in vitro and in vivo . Methods In vitro , hypertrophic scar-derived fibroblasts (HSFs) were isolated from human HTSs and cultured. HSFs were treated with (0, 10, 50, 100 μmol/L) Sal-B. Cell proliferation and migration were evaluated by EdU, wound healing, and transwell assays. The protein and mRNA levels of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 were detected by Western blots and real-time PCR. In vivo , tension stretching devices were fixed on incisions for HTS formation. The induced scars were treated with 100 μL of Sal-B/PBS per day according to the concentration of the group and followed up for 7 or 14 days. The scar condition, collagen deposition, and α-SMA expression were analyzed by gross visual examination, H&amp;E, Masson, picrosirius red staining, and immunofluorescence. Results In vitro, Sal-B inhibited HSF proliferation, migration, and downregulated the expression of TGFβI, Smad2, Smad3, α-SMA, COL1, and COL3 in HSFs. In vivo , 50 and 100 μmol/L Sal-B significantly reduced scar size in gross and cross-sectional observations, with decreased α-SMA expression and collagen deposition in the tension-induced HTS model. Conclusions Our study demonstrated that Sal-B inhibits HSFs proliferation, migration, fibrotic marker expression and attenuates HTS formation in a tension-induced HTS model in vivo . No Level Assigned This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .</abstract><cop>New York</cop><pub>Springer US</pub><pmid>36810832</pmid><doi>10.1007/s00266-023-03279-1</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-216X
ispartof Aesthetic plastic surgery, 2023-08, Vol.47 (4), p.1587-1597
issn 0364-216X
1432-5241
language eng
recordid cdi_proquest_miscellaneous_2779346317
source Springer Nature
subjects Evidence-based medicine
Medicine
Medicine & Public Health
Original Article
Otorhinolaryngology
Plastic Surgery
title Salvianolic Acid B Attenuates Hypertrophic Scar Formation In Vivo and In Vitro
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A17%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Salvianolic%20Acid%20B%20Attenuates%20Hypertrophic%20Scar%20Formation%20In%20Vivo%20and%20In%20Vitro&rft.jtitle=Aesthetic%20plastic%20surgery&rft.au=Chong,%20Chio-Hou&rft.date=2023-08-01&rft.volume=47&rft.issue=4&rft.spage=1587&rft.epage=1597&rft.pages=1587-1597&rft.issn=0364-216X&rft.eissn=1432-5241&rft_id=info:doi/10.1007/s00266-023-03279-1&rft_dat=%3Cproquest_cross%3E2843961453%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-a804c96cd757499bc326381f5a6666c1f5e2f1eac6e45bfa63e420c12466c8193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2843961453&rft_id=info:pmid/36810832&rfr_iscdi=true